why choose us

First received: July 27, 2023

Clinical Trial: Study of Intravenous ZMA001 in Healthy Subjects

Study Status: Completed

Recruit Status: RECRUITING

Condition: Pulmonary Arterial Hypertension PAH

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous ZMA001 in Healthy Subjects

Brief Summary: Background:A number of diseases can cause a type of lung injury called pulmonary arterial hypertension (PAH).Most people who develop PAH do not survive more than a few years.A new study drug (ZMA001) may help.ZMA001 is a monoclonal antibody.This type of drug consists of proteins, made in a facility, that are very similar to proteins in a human body.But before giving ZMA001 to people sick with PAH, researchers want to find out how the drug affects healthy people.Objective:To test a drug (ZMA001) in healthy…

Read more